Vagal nerve stimulation (VNS) therapy had limited success since appropriate consideration of vagal afferent central transmission is key for optimally effectiveness. Our evidence suggests that the hypothalamus contribute to therapeutic efficacy in heart failure.
I'm looking for
6 months ago
I am looking for an industrial partner to test commercially available vagal nerve stimulation devices in animal models. I previously partnered with LivaNova for 10 years.
About
Maps and modulates vagal–autonomic circuits governing cardiovascular and neural function. Combines in vivo electrophysiology, stimulation parameter optimization, and computational neuroimaging to elucidate pathways and translate noninvasive and implantable bioelectronic therapies for heart failure, neurological disease, and inflammation.
Partnering listings
Learn more
No Partnering listings yet
This innovator has not added partnering listings yet. For now, explore their publications, funding, and other profile details to identify promising topics to connect on.